Dental implants are one of the most successful, effective methods of tooth replacement. And while success rates have been reported as high as 98%, dental implant failure is still an issue that some have to face. In most cases, it’s the body’s inflammatory response that causes rejection of the implant, but researchers in Canada claim that they may have a solution in the form of a new implant coating.
According to a recent article from the Dental Tribune, the coating helps disrupt the inflammatory immune mechanism, preventing the risk of failure and the need for anti-inflammatory drugs. The polymer was developed by Dr. Kyle Battiston, a postdoctoral fellow at the Faculty of Dentistry and an Institute of Biomaterials and Biomedical Engineering at the University of Toronto graduate. It’s original purpose was to be used by tissue engineers to assist in the growing of cells. Through clinical trials, Battiston and colleagues found that when they coated implants with the biomaterial, it interacted with white blood cells, calming the body’s immune response.
“We’ve learned this family of materials can retain its anti-inflammatory character while adapting diverse physical properties,” claimed Battiston. “The material could thus be used for a wide variety of medical treatments.”
Battiston has hopes to market his discovery through his startup company, KSP2, sometime in the next five years.